Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphospholipid autoantibodies (aPL) form to such ubiquitous compounds as phospholipids (PL). In this paper, we demonstrate that many,...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Autores principales:	Hörkkö, S, Miller, E, Dudl, E, Reaven, P, Curtiss, L K, Zvaifler, N J, Terkeltaub, R, Pierangeli, S S, Branch, D W, Palinski, W, Witztum, J L
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Clinical Investigation 1996
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507492/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8698874/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118854
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!